Showing results (11-20 of 22) with videos related to
Sort By:
Pageof 3
World Neurosurgery|December 10, 2016
Interleukin 6 in the Cerebrospinal Fluid as a Biomarker for Onset of Vasospasm and Ventriculitis After Severe Subarachnoid HemorrhageMarkus Lenski, Volker Huge, Josef Briegel, et al.Neurosurgical Focus|November 2, 2019
Significance of cerebrospinal fluid inflammatory markers for diagnosing external ventricular drain-associated ventriculitis in patients with severe traumatic brain injuryMarkus Lenski, Annamaria Biczok, Katrin Neufischer, et al.Journal of Clinical Pharmacology|March 16, 2019
Improving the Pharmacology Curriculum at a German Medical School: A Structured Plan Based on a Student-Guided Large-Scale StudyJulius Steffen, Markus Lenski, Florian E Herrmann, et al.World Neurosurgery|October 1, 2018
Role of Cerebrospinal Fluid Markers for Predicting Shunt-Dependent Hydrocephalus in Patients with Subarachnoid Hemorrhage and External Ventricular Drain PlacementMarkus Lenski, Annamaria Biczok, Volker Huge, et al.Journal of Neurosurgical Anesthesiology|March 2, 2018
Inflammatory Markers in Serum and Cerebrospinal Fluid for Early Detection of External Ventricular Drain-associated Ventriculitis in Patients With Subarachnoid HemorrhageMarkus Lenski, Volker Huge, Michael Schmutzer, et al.International Journal of Computer Assisted Radiology and Surgery|June 24, 2018
Dual-room CT with a sliding gantry for intraoperative imaging: feasibility and workflow analysis of an interdisciplinary conceptMarkus Lenski, Johann Hofereiter, Nicole Terpolilli, et al.Acta Neurochirurgica|March 6, 2021
Past medical history of tumors other than meningioma is a negative prognostic factor for tumor recurrence in meningiomas WHO grade IAnnamaria Biczok, Philipp Karschnia, Raffaela Vitalini, et al.Acta Neurochirurgica|March 28, 2019
Diffusion-weighted magnetic resonance imaging for detection of postoperative intracranial pyogenic abscesses in neurosurgeryChristoph Schwartz, Markus Lenski, Alexander Romagna, et al.Journal of Neuro-Oncology|September 8, 2016
Re-irradiation strategies in combination with bevacizumab for recurrent malignant gliomaOliver Schnell, Jun Thorsteinsdottir, Daniel Felix Fleischmann, et al.European Journal of Cancer (Oxford, England : 1990)|December 12, 2018
Contrast enhancement is a prognostic factor in IDH1/2 mutant, but not in wild-type WHO grade II/III glioma as confirmed by machine learningBogdana Suchorska, Ulrich Schüller, Annamaria Biczok, et al.Pageof 3